Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colonic Neoplasms 3Postoperative Complications 1Ileus 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Anastomotic Leak 1

Interventions

pembrolizumab 1265Specimen Handling 926Magnetic Resonance Spectroscopy 830Carboplatin 823Cyclophosphamide 800Cisplatin 723Nivolumab 669Paclitaxel 627Radiotherapy 611Gemcitabine 573Biopsy 557Bevacizumab 478Dexamethasone 438fludarabine 407Docetaxel 380venetoclax 368Oxaliplatin 364Capecitabine 358Fluorouracil 355atezolizumab 350durvalumab 332Rituximab 330Drug Therapy 326Doxorubicin 316Radiosurgery 315Standard of Care 309Blood Specimen Collection 308Pemetrexed 305Ipilimumab 299Radiation 286

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Colectomy × 1 year × Clear all
NCT07289568 2025-12-17

SPARROW

Acibadem University

Enrolling by invitation
140 enrolled
Gastrointestinal

Colonic Neoplasms, Postoperative Complications, Colorectal Neoplasms, Ileus, Anastomotic Leak

NCT03432806 2025-12-02

A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors

Memorial Sloan Kettering Cancer Center

Active not recruiting
51 enrolled
Gastrointestinal

Colonic Neoplasms, Carcinoma, Hepatocellular

NCT06124378 2025-09-24

Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer

First Affiliated Hospital of Guangxi Medical University

Phase 2 Active not recruiting
60 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡